These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8610642
1. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma. Konski AA, Domenico D, Irving D, Tyrkus M, Neisler J, Phibbs G, Mah J, Eggleston W. Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642 [Abstract] [Full Text] [Related]
2. Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Konski A, Domenico D, Tyrkus M, Irving D, Neisler J, Phibbs G, Zeidner S, Eggleston W. Int J Radiat Oncol Biol Phys; 1996 Jul 15; 35(5):935-40. PubMed ID: 8751402 [Abstract] [Full Text] [Related]
3. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. Mauland KK, Wik E, Hoivik EA, Kusonmano K, Halle MK, Berg A, Haugland HK, Øyan AM, Kalland KH, Stefansson IM, Akslen LA, Krakstad C, Trovik J, Werner HM, Salvesen HB. Oncotarget; 2017 Feb 07; 8(6):9696-9707. PubMed ID: 28039471 [Abstract] [Full Text] [Related]
4. Clinicopathologic and immunohistochemical features and microsatellite status of endometrial cancer of the uterine isthmus. Watanabe Y, Nakajima H, Nozaki K, Ueda H, Obata K, Hoshiai H, Noda K. Int J Gynecol Pathol; 2001 Oct 07; 20(4):368-73. PubMed ID: 11603221 [Abstract] [Full Text] [Related]
5. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Mod Pathol; 2000 Apr 07; 13(4):379-88. PubMed ID: 10786803 [Abstract] [Full Text] [Related]
6. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB. Cancer; 1986 Oct 01; 58(7):1518-25. PubMed ID: 3742470 [Abstract] [Full Text] [Related]
7. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer. Nagai N, Oshita T, Fujii T, Kioka H, Katsube Y, Ohama K. Oncol Rep; 2000 Oct 01; 7(3):551-9. PubMed ID: 10767367 [Abstract] [Full Text] [Related]
8. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Gynecol Oncol; 2000 Apr 01; 77(1):55-65. PubMed ID: 10739691 [Abstract] [Full Text] [Related]
9. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Murphy KT, Rotmensch J, Yamada SD, Mundt AJ. Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1272-6. PubMed ID: 12654437 [Abstract] [Full Text] [Related]
10. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy. Genest DR, Sheets E, Lage JM. Am J Clin Pathol; 1994 Sep 01; 102(3):341-8. PubMed ID: 8085558 [Abstract] [Full Text] [Related]
11. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study. Zaino RJ, Davis AT, Ohlsson-Wilhelm BM, Brunetto VL. Int J Gynecol Pathol; 1998 Oct 01; 17(4):312-9. PubMed ID: 9785131 [Abstract] [Full Text] [Related]
12. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma. van der Putten HW, Baak JP, Koenders TJ, Kurver PH, Stolk HG, Stolte LA. Cancer; 1989 Apr 01; 63(7):1378-87. PubMed ID: 2920365 [Abstract] [Full Text] [Related]
13. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors]. Shimizu K. Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr 01; 47(4):413-8. PubMed ID: 7730696 [Abstract] [Full Text] [Related]
14. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis]. Köhler U, Horn LG, Naumann G, Nenning H, Bilek K. Zentralbl Gynakol; 1995 Apr 01; 117(4):213-6. PubMed ID: 7778358 [Abstract] [Full Text] [Related]
15. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Gynecol Oncol; 1999 Sep 01; 74(3):385-94. PubMed ID: 10479498 [Abstract] [Full Text] [Related]
16. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma. Punnonen R, Mattila J, Kuoppala T, Koivula T. J Cancer Res Clin Oncol; 1993 Sep 01; 119(7):426-9. PubMed ID: 8491764 [Abstract] [Full Text] [Related]
17. Serous papillary adenocarcinoma of the endometrium. Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Sasano H, Comerford J, Wilkinson DS, Schwartz A, Garrett CT. Cancer; 1990 Apr 01; 65(7):1545-51. PubMed ID: 1690076 [Abstract] [Full Text] [Related]
18. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters. Susini T, Rapi S, Savino L, Boddi V, Berti P, Massi G. Am J Obstet Gynecol; 1994 Feb 01; 170(2):527-34. PubMed ID: 8116708 [Abstract] [Full Text] [Related]
19. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma]. Li M, Wang Z, Zhao L, Li X, Wang J, Zhang C, Wei L. Zhonghua Fu Chan Ke Za Zhi; 2014 Jun 01; 49(6):455-9. PubMed ID: 25169640 [Abstract] [Full Text] [Related]
20. Comparison between clinical and surgical staging for endometrial cancer in Thailand. Buranawattanachoke S, Leelahakorn S, Tangjitgamol S, Manusirivithaya S, Khunnarong J. Asian Pac J Cancer Prev; 2009 Jun 01; 10(4):685-90. PubMed ID: 19827895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]